🇺🇸 low-dose neuroleptanalgesia in United States

low-dose neuroleptanalgesia (low-dose neuroleptanalgesia) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

low-dose neuroleptanalgesia in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is low-dose neuroleptanalgesia approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for low-dose neuroleptanalgesia in United States?

RenJi Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.